Christian P Behrenbruch

Title: The Innovative Contributions of Christian P Behrenbruch

Introduction

Christian P Behrenbruch is a notable inventor based in Inglewood, CA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of antigen binding constructs. With a total of 5 patents to his name, Behrenbruch's work has the potential to impact therapeutic strategies in immunology.

Latest Patents

Among his latest patents are innovative constructs that target specific proteins involved in immune responses. One of his patents focuses on antigen binding constructs to CD8, which includes antibodies and antibody fragments such as scFv, minibodies, and cys-diabodies. These constructs are designed to bind to CD8, and the methods of use are detailed within the patent documentation. Another significant patent involves antigen binding constructs to CD3, which similarly includes antibodies and fragments that bind to CD3, along with described methods of use.

Career Highlights

Christian P Behrenbruch is currently associated with Imaginab, Inc., where he continues to advance his research and development efforts. His work at Imaginab has positioned him as a key player in the field of targeted therapies, particularly in the context of cancer treatment.

Collaborations

Some of his notable coworkers include David T Ho and Tove Olafsen, who contribute to the collaborative environment that fosters innovation and research excellence.

Conclusion

Christian P Behrenbruch's contributions to the field of biomedical engineering through his patents and work at Imaginab, Inc. highlight his role as a significant inventor in the industry. His innovative approaches to antigen binding constructs are paving the way for future advancements in immunotherapy.